HealthMedical Research
Pancreatic Cancer Vaccine Shows Promise in First Human Trial
A Johns Hopkins vaccine targeting KRAS mutations safely triggered immune responses in 90% of participants, a breakthrough in pancreatic cancer prevention.
—4 min read